Compare CRWD & MDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRWD | MDT |
|---|---|---|
| Founded | 2011 | 1949 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 118.2B | 125.3B |
| IPO Year | 2019 | N/A |
| Metric | CRWD | MDT |
|---|---|---|
| Price | $464.80 | $98.83 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 43 | 19 |
| Target Price | ★ $549.63 | $108.44 |
| AVG Volume (30 Days) | 2.2M | ★ 6.0M |
| Earning Date | 12-02-2025 | 02-17-2026 |
| Dividend Yield | N/A | ★ 2.85% |
| EPS Growth | N/A | ★ 12.98 |
| EPS | N/A | ★ 3.69 |
| Revenue | $4,565,168,000.00 | ★ $34,758,000,000.00 |
| Revenue This Year | $23.94 | $8.61 |
| Revenue Next Year | $22.04 | $5.86 |
| P/E Ratio | ★ N/A | $27.04 |
| Revenue Growth | ★ 22.05 | 5.34 |
| 52 Week Low | $298.00 | $79.55 |
| 52 Week High | $566.90 | $106.33 |
| Indicator | CRWD | MDT |
|---|---|---|
| Relative Strength Index (RSI) | 40.57 | 54.11 |
| Support Level | $451.29 | $95.17 |
| Resistance Level | $486.55 | $101.32 |
| Average True Range (ATR) | 11.82 | 1.32 |
| MACD | -0.22 | 0.19 |
| Stochastic Oscillator | 39.26 | 65.53 |
CrowdStrike is a cloud-based cybersecurity company specializing in next-generation security verticals such as endpoint, cloud workload, identity, and security operations. CrowdStrike's primary offering is its Falcon platform that offers a proverbial single pane of glass for an enterprise to detect and respond to security threats attacking its IT infrastructure. The Texas-based firm was founded in 2011 and went public in 2019.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.